Discover
SLN
Silence Therapeutics plc
10.85
1 x 10.60
1 x 11.00
bid
ask
+
0.36
3.43%
1 @ 04:00 PM
10.69 -0.16 (1.47%)
| Ytd | 78.45% | |
| 1y | 75.85% |
10.68
day range
10.99
4.19
52 week range
11.19
| Open | 10.71 | Prev Close | 10.49 | Low | 10.68 | High | 10.99 | Mkt Cap | 512.49M |
| Vol | 161.02K | Avg Vol | 388.92K | EPS | -1.56 | P/E | -6.96 | Forward P/E | N/A |
| Beta | 1.38 | Short Ratio | 2.36 | Inst. Own | 62.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 7.99 | 200-d Avg | 6.60 | 1yr Est | 53.70 |
| Income Statement | |||
| Total Revenue | 422.00K | ||
| Revenues (USD) | 422.00K | ||
| Cost of Revenue | 11.00K | ||
| Gross Profit | 411.00K | ||
| Operating Expenses | 16.15M | ||
| Research and Development Expense | 9.12M | ||
| Selling, General and Administrative Expense | 7.03M | ||
| Operating Income | -15.74M | ||
| Net Income | -14.96M | ||
| Net Income Common Stock | -14.96M | ||
| Net Income Common Stock (USD) | -14.96M | ||
| Consolidated Income | -14.96M | ||
| Earnings per Basic Share | -0.33 | ||
| Earnings per Basic Share (USD) | -0.33 | ||
| Earnings per Diluted Share | -0.33 | ||
| Earning Before Interest & Taxes (EBIT) | -14.96M | ||
| Earning Before Interest & Taxes (USD) | -14.96M | ||
| Weighted Average Shares | 141.70M | ||
| Weighted Average Shares Diluted | 141.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.66M | ||
| Cash and Equivalents (USD) | 5.66M | ||
| Investments | 64.42M | ||
| Investments Current | 64.42M | ||
| Current Assets | 102.85M | ||
| Property, Plant & Equipment Net | 1.54M | ||
| Total Assets | 115.12M | ||
| Debt Current | 93.00K | ||
| Total Debt | 136.00K | ||
| Current Liabilities | 10.46M | ||
| Debt Non-Current | 43.00K | ||
| Total Liabilities | 65.72M | ||
| Accumulated Retained Earnings (Deficit) | 577.53M | ||
| Accumulated Other Comprehensive Income | 3.37M | ||
| Shareholders Equity | -49.40M | ||
| Shareholders Equity (USD) | -49.40M | ||
| Assets Non-Current | 12.27M | ||
| Total Debt (USD) | 136.00K | ||
| Deferred Revenue | 55.22M | ||
| Goodwill and Intangible Assets | 10.61M | ||
| Liabilities Non-Current | 55.26M | ||
| Trade and Non-Trade Payables | 10.37M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 106.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.60M | ||
| Net Cash Flow from Investing | 10.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 10.00M | ||
| Net Cash Flow from Operations | -15.60M | ||
| Effect of Exchange Rate Changes on Cash | -17.00K | ||
| Share Based Compensation | 2.45M | ||